Supplementary Data for "Proof-of-concept and randomized, placebo-controlled trials of an FcRn inhibitor, batoclimab, for thyroid eye disease"

Published: 26 June 2023| Version 1 | DOI: 10.17632/m9fmzz3rk5.1
Contributor:
Jonathan Janes

Description

Supplemental data file.

Files

Categories

Autoimmunity, Clinical Trial, Thyroid Eye Disease, Autoantibody, Immunoglobulin G

Funding

Immunovant Sciences GmbH

Licence